FDA 510(k)

VI°Port™ 肝脏保护系统

K号: K260456 · 2026-06-01

决定日期2026-06-01

产品代码KDN

咨询委员会GU 请注意，由于您只提供了“GU”这个词，我无法提供完整的翻译。如果您能提供完整的句子或段落，我将能够为您提供准确的翻译。

决定实质等同

器械摘要

VI°Port™ Liver Preservation System is the device name listed in this FDA 510(k) record. The listed applicant is Traferox Technologies, Inc.. It received FDA 510(k) clearance on 2026-06-01 under 510(k) number K260456. The device is classified under product code KDN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the VI°Port™ Liver Preservation System?

VI°Port™ Liver Preservation System is a medical device that received FDA 510(k) clearance on 2026-06-01. The listed applicant is Traferox Technologies, Inc.. The 510(k) number is K260456.

When did VI°Port™ Liver Preservation System receive FDA 510(k) clearance?

VI°Port™ Liver Preservation System received FDA 510(k) clearance on 2026-06-01, under 510(k) number K260456.

Who is the listed applicant for VI°Port™ Liver Preservation System?

FDA 510(k)记录中列出Traferox Technologies, Inc.为申请人。这本身并不能确立该设备制造商的身份。

What is the FDA product code for VI°Port™ Liver Preservation System?

The FDA product code for VI°Port™ Liver Preservation System is KDN.

列明Traferox Technologies, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K261913X°Port 心脏保护系统 K243870X°Port 肺脏保护系统；X°Port 肺脏保护解决方案 K240650LungProtect

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。